Greenwich LifeSciences reported net income of -$5.66M for the quarter ended Mar 2026. This income statement covers 27 quarters of results from Sep 2019 through Mar 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 12.92M | 12.99M | 13.15M | 12.95M | 12.77M | 12.85M | 12.85M | 12.85M | 12.85M | 12.85M | 12.85M | 12.88M | 13.07M | 13.14M | 13.15M | 13.19M | 13.47M | 13.79M | 14.30M | 14.67M | |||||||
| Operating items | |||||||||||||||||||||||||||
| Research & DevelopmentR&D | 0.56M | 0.66M | 2.06M | 1.66M | 0.63M | 1.72M | 2.46M | 1.83M | 1.38M | 2.16M | 2.33M | 2.19M | 2.31M | 2.29M | 8.69M | 2.27M | 3.42M | 3.27M | 8.27M | 5.21M | |||||||
| Selling, General & AdministrativeSG&A | 0.20M | 0.21M | 0.31M | 0.33M | 0.14M | 0.66M | 0.44M | 0.41M | 0.37M | 0.34M | 0.50M | 0.34M | 0.35M | 0.44M | 1.02M | 0.50M | 0.35M | 0.47M | 0.91M | 0.52M | |||||||
| Operating ExpensesOpex | 0.75M | 0.87M | 2.38M | 1.99M | 0.77M | 2.38M | 2.89M | 2.24M | 1.75M | 2.50M | 2.84M | 2.54M | 2.66M | 2.73M | 9.71M | 2.77M | 3.77M | 3.73M | 9.18M | 5.73M | |||||||
| Operating IncomeOp. Inc | -0.75M | -0.87M | -2.38M | -1.99M | -0.77M | -2.38M | -2.89M | -2.24M | -1.75M | -2.50M | -2.84M | -2.54M | -2.66M | -2.73M | -9.71M | -2.77M | -4.05M | -4.17M | -7.94M | -5.73M | |||||||
| EBIT | -0.75M | -0.87M | -2.38M | -1.99M | -0.77M | -2.38M | -2.89M | -2.24M | -1.75M | -2.50M | -2.84M | -2.54M | -2.66M | -2.73M | -9.71M | -2.77M | -4.05M | -4.17M | -7.94M | -5.73M | |||||||
| Non-operating items | |||||||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.00M | 0.00M | 0.02M | 0.02M | 0.03M | 0.06M | 0.10M | 0.12M | 0.12M | 0.11M | 0.09M | 0.06M | 0.05M | 0.06M | 0.04M | 0.02M | 0.02M | 0.02M | 0.02M | 0.07M | |||||||
| Net income details | |||||||||||||||||||||||||||
| EBT | -0.75M | -0.86M | -2.36M | -1.97M | -0.75M | -2.32M | -2.79M | -2.12M | -1.63M | -2.39M | -2.75M | -2.47M | -2.61M | -2.67M | -9.67M | -2.74M | -4.03M | -4.15M | -7.92M | -5.66M | |||||||
| Profit After TaxPAT | -0.75M | -0.86M | -2.36M | -1.97M | -0.75M | -2.32M | -2.79M | -2.12M | -1.63M | -2.39M | -2.75M | -2.47M | -2.61M | -2.67M | -9.67M | -2.74M | -3.75M | -3.71M | -9.15M | -5.66M | |||||||
| Income from Continuing OperationsIncome (Continuing) | -0.75M | -0.86M | -2.36M | -1.97M | -0.75M | -2.32M | -2.79M | -2.12M | -1.63M | -2.39M | -2.75M | -2.47M | -2.61M | -2.67M | -9.67M | -2.74M | -4.03M | -4.15M | -7.92M | -5.66M | |||||||
| Consolidated Net IncomeConsol Net Inc. | -0.75M | -0.86M | -2.36M | -1.97M | -0.75M | -2.32M | -2.79M | -2.12M | -1.63M | -2.39M | -2.75M | -2.47M | -2.61M | -2.67M | -9.67M | -2.74M | -4.03M | -4.15M | -7.92M | -5.66M | |||||||
| Income towards Parent CompanyParent Net Inc | -0.75M | -0.86M | -2.36M | -1.97M | -0.75M | -2.32M | -2.79M | -2.12M | -1.63M | -2.39M | -2.75M | -2.47M | -2.61M | -2.67M | -9.67M | -2.74M | -4.03M | -4.15M | -7.92M | -5.66M | |||||||
| Net Income towards Common StockholdersNet Income | -0.75M | -0.86M | -2.36M | -1.97M | -0.75M | -2.32M | -2.79M | -2.12M | -1.63M | -2.39M | -2.75M | -2.47M | -2.61M | -2.67M | -9.67M | -2.74M | -4.54M | -4.15M | -7.92M | -5.66M | |||||||
| Additional items | |||||||||||||||||||||||||||
| EPS (Basic) | -0.06 | -0.07 | -0.18 | -0.15 | -0.06 | -0.18 | -0.22 | -0.17 | -0.13 | -0.19 | -0.21 | -0.19 | -0.20 | -0.20 | -0.74 | -0.21 | -0.34 | -0.30 | -0.59 | -0.39 | |||||||
| EPS (Diluted) | -0.06 | -0.18 | -0.22 | -0.17 | -0.13 | -0.19 | -0.21 | -0.19 | -0.20 | -0.20 | -0.74 | -0.21 | -0.34 | -0.30 | -0.59 | -0.39 | |||||||||||
| Shares Outstanding | 12.90M | 12.97M | 12.94M | 13.06M | 12.92M | 12.82M | 12.91M | 12.85M | 12.85M | 12.85M | 12.85M | 12.86M | 12.91M | 13.14M | 13.01M | 13.17M | 13.37M | 13.64M | 13.53M | 14.57M | |||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 12.92M | 12.82M | 12.91M | 12.85M | 12.85M | 12.85M | 12.85M | 12.86M | 12.91M | 13.14M | 13.01M | 13.17M | 13.37M | 13.64M | 13.53M | 14.57M | |||||||||||
| EBITDA | -0.75M | -0.87M | -2.38M | -1.99M | -0.77M | -2.38M | -2.89M | -2.24M | -1.75M | -2.50M | -2.84M | -2.54M | -2.66M | -2.73M | -9.71M | -2.77M | -4.05M | -4.17M | -7.94M | -5.73M |